Transaction #6641 · Form 4 · 0001628280-25-050825
OptimizeRx Corp · Stock award · Stock Option
OptimizeRx Corp · Transacted August 21, 2025 · Filed November 10, 2025
What does this filing report?
An SEC Form 4 filing for OptimizeRx Corp records a stock award involving Stock Option on August 21, 2025. The reported quantity was 23,437. The filing date is November 10, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- OptimizeRx Corp
- Company CIK
- 0001448431
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 23,437
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 46,874
- Ownership description
- Not reported
- SEC acceptance time
- Nov 10, 2025, 9:55 AM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Merrell Brendan W. ↗
CHIEF OPERATING OFFICER
CIK 0002090383
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 23,437
- Conversion / exercise price
- 16.14
- Exercise date
- Not reported
- Expiration date
- August 21, 2030
Filing footnotes & remarks
- F1
- Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.
- F2
- These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- F3
- The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.
Remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.